Germline genetic testing of patients with penile carcinoma.

Authors

Guru P. Sonpavde

Guru P. Sonpavde

AdventHealth Cancer Institute, Orlando, FL

Guru P. Sonpavde , Sarah M. Nielsen , Brandie Heald , Kathryn E. Hatchell , Edward D. Esplin , Amin Nassar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 10)

DOI

10.1200/JCO.2023.41.6_suppl.10

Abstract #

10

Poster Bd #

D15

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

Hereditary breast and ovarian cancer syndrome: A misnomer?

Hereditary breast and ovarian cancer syndrome: A misnomer?

First Author: Jessica M. Weiss

Poster

2023 ASCO Genitourinary Cancers Symposium

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

First Author: Channing Judith Paller

Poster

2022 ASCO Genitourinary Cancers Symposium

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

First Author: Channing Judith Paller

Poster

2020 Gastrointestinal Cancers Symposium

Changing the landscape of germline testing in patients with pancreatic adenocarcinoma.

Changing the landscape of germline testing in patients with pancreatic adenocarcinoma.

First Author: Aly Athens